Market Research

Helicobacter Pylori Diagnostics Market By Test Type (Non-Invasive Test, Invasive Test), By Method (Laboratory Based Test, Point of Care Test), By End User (Hospitals, Diagnostics Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 20

Best Price Guarantee Length Publisher Published Date SKU
from $3,840 261 Pages Allied Market Research May, 2023 ALMR18132543
Best Price Guarantee
Price from $3,840
Length 261 Pages
Publisher Allied Market Research
Published Date May, 2023
SKU ALMR18132543

Helicobacter Pylori Diagnostics Market By Test Type (Non-Invasive Test, Invasive Test), By Method (Laboratory Based Test, Point of Care Test), By End User (Hospitals, Diagnostics Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032


Helicobacter pylori (H. pylori) is a type of bacteria that can infect the stomach and cause various digestive problems, such as gastritis, peptic ulcers, and stomach cancer. H. pylori infection can cause a variety of gastrointestinal symptoms, including abdominal pain, nausea, vomiting, and bloating. In some cases, it can lead to more serious conditions such as gastritis, peptic ulcer disease, and stomach cancer. Testing for H. pylori is important to diagnose and treat the infection. Several methods are used to test H. pylori, including blood test, breath test, stool test, and endoscopy test.  

Blood tests detect antibodies against H. pylori in the bloodstream, while breath tests measure the presence of carbon dioxide in a patient's breath after ingestion of a special solution. Stool tests detect H. pylori antigens in a patient's stool, while endoscopy with biopsy involves taking a small tissue sample from the stomach lining for laboratory analysis. The global Helicobacter pylori diagnostics market is majorly driven by an increase in prevalence of infectious diseases such as gastric cancer, rise in advancements in technology to diagnose H. pylori infection, and surge in awareness about H. pylori testing. Rise in advances in diagnostic technology have made it easier and more efficient to detect H. pylori infection, which drives the demand for diagnostic tests and supports the market growth. For instance, breath tests are non-invasive tests that detect H. pylori by measuring the presence of carbon dioxide in a patient's breath. This test is highly accurate and can be performed in a doctor's office. 

In addition, rapid urease tests are diagnostic tests that detect H. pylori by measuring the enzyme urease, which is produced by the bacteria. These tests are quick & easy to perform and provide results in as little as 30 minutes. These advances in diagnostic technology drive the growth of the Helicobacter pylori diagnostics market. Furthermore, surge in demand for point-of-care testing allows rapid and accurate diagnosis of the infection without the need for laboratory testing, which drives the demand for H. pylori testing and supports the market growth. However, the lack of awareness about H. pyloric infection and availability of advanced diagnostic tests and shortage of skilled professionals to diagnostic tests in developing countries are the factors that restrain the market growth. 

The Helicobacter pylori diagnostics market is segmented into test type, method, end user, and region. By test type, the market is divided into non-invasive test and invasive test. Non-invasive test segment is further categorized into the serology test, stool antigen test, and carbon urea breath test. By method, the market is bifurcated into laboratory-based tests and point of care test. By end user, the market is classified into hospitals, diagnostics laboratories, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global Helicobacter pylori diagnostics market are Abbott Laboratories, Avanos Medical, Inc., Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Gulf Coast Scientific, Meridian Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc. Key players operating in the market have adopted product approval, acquisition, and agreement as their key strategies to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the helicobacter pylori diagnostics market analysis from 2022 to 2032 to identify the prevailing helicobacter pylori diagnostics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the helicobacter pylori diagnostics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global helicobacter pylori diagnostics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Test Type

Non-Invasive Test
Type
Serology Test
Stool Antigen Test
Carbon Urea Breath Test
Invasive Test

By Method

Laboratory Based Test
Point of Care Test

By End User

Diagnostics Laboratories
Others
Hospitals

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Avanos Medical, Inc.
Gulf Coast Scientific
Bio-Rad Laboratories, Inc. 
Biohit Oyj
Thermo Fisher Scientific Inc. 
Cardinal Health Inc.
Quidel Corporation
Meridian Bioscience, Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.


CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of infectious diseases
3.4.1.2. Increase in demand for non-invasive diagnostic procedures
3.4.1.3. Development of new and improved testing methods
3.4.2. Restraints
3.4.2.1. Lack of awareness and shortage of skilled professionals
3.4.3. Opportunities
3.4.3.1. Rise in demand for point of care H. pylori testing
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Non-Invasive Test
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Non-Invasive Test Helicobacter Pylori Diagnostics Market by Type
4.3. Invasive Test
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD
5.1. Overview
5.1.1. Market size and forecast
5.2. Laboratory Based Test
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Point of Care Test
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Diagnostics Laboratories
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Test Type
7.2.3. Market size and forecast, by Method
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Test Type
7.2.5.1.3. Market size and forecast, by Method
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Test Type
7.2.5.2.3. Market size and forecast, by Method
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Test Type
7.2.5.3.3. Market size and forecast, by Method
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Test Type
7.3.3. Market size and forecast, by Method
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Test Type
7.3.5.1.3. Market size and forecast, by Method
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Test Type
7.3.5.2.3. Market size and forecast, by Method
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Test Type
7.3.5.3.3. Market size and forecast, by Method
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Test Type
7.3.5.4.3. Market size and forecast, by Method
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Test Type
7.3.5.5.3. Market size and forecast, by Method
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Test Type
7.3.5.6.3. Market size and forecast, by Method
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Test Type
7.4.3. Market size and forecast, by Method
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Test Type
7.4.5.1.3. Market size and forecast, by Method
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Test Type
7.4.5.2.3. Market size and forecast, by Method
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Test Type
7.4.5.3.3. Market size and forecast, by Method
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Test Type
7.4.5.4.3. Market size and forecast, by Method
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Test Type
7.4.5.5.3. Market size and forecast, by Method
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Test Type
7.4.5.6.3. Market size and forecast, by Method
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Test Type
7.5.3. Market size and forecast, by Method
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Test Type
7.5.5.1.3. Market size and forecast, by Method
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Test Type
7.5.5.2.3. Market size and forecast, by Method
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Test Type
7.5.5.3.3. Market size and forecast, by Method
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Test Type
7.5.5.4.3. Market size and forecast, by Method
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Thermo Fisher Scientific Inc. 
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Meridian Bioscience, Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Key strategic moves and developments
9.3. Bio-Rad Laboratories, Inc. 
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Abbott Laboratories
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. F. Hoffmann-La Roche Ltd.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Cardinal Health Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Avanos Medical, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Gulf Coast Scientific
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Quidel Corporation
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Biohit Oyj
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 02. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR NON-INVASIVE TEST, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GLOBAL NON-INVASIVE TEST HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 04. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR INVASIVE TEST, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 06. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR LABORATORY BASED TEST, BY REGION, 2022-2032 ($MILLION)
TABLE 07. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR POINT OF CARE TEST, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 09. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR DIAGNOSTICS LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 11. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 17. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 18. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 19. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 21. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 22. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 24. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 25. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 27. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 28. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 31. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 32. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 34. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 35. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 37. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 38. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 40. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 41. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 43. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 44. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 53. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 54. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 56. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 57. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 59. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 60. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 71. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 72. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 74. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 75. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 76. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 78. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 79. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 81. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 82. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 84. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
TABLE 85. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
TABLE 87. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
TABLE 88. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
TABLE 89. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
TABLE 90. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
TABLE 91. MERIDIAN BIOSCIENCE, INC.: KEY EXECUTIVES
TABLE 92. MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT
TABLE 93. MERIDIAN BIOSCIENCE, INC.: PRODUCT SEGMENTS
TABLE 94. MERIDIAN BIOSCIENCE, INC.: PRODUCT PORTFOLIO
TABLE 95. MERIDIAN BIOSCIENCE, INC.: KEY STRATERGIES
TABLE 96. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 97. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 98. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
TABLE 99. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 100. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 101. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 102. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 103. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 104. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 105. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 106. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 107. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 108. CARDINAL HEALTH INC.: KEY EXECUTIVES
TABLE 109. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
TABLE 110. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
TABLE 111. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
TABLE 112. AVANOS MEDICAL, INC.: KEY EXECUTIVES
TABLE 113. AVANOS MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 114. AVANOS MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 115. AVANOS MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 116. GULF COAST SCIENTIFIC: KEY EXECUTIVES
TABLE 117. GULF COAST SCIENTIFIC: COMPANY SNAPSHOT
TABLE 118. GULF COAST SCIENTIFIC: PRODUCT SEGMENTS
TABLE 119. GULF COAST SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 120. QUIDEL CORPORATION: KEY EXECUTIVES
TABLE 121. QUIDEL CORPORATION: COMPANY SNAPSHOT
TABLE 122. QUIDEL CORPORATION: PRODUCT SEGMENTS
TABLE 123. QUIDEL CORPORATION: PRODUCT PORTFOLIO
TABLE 124. BIOHIT OYJ: KEY EXECUTIVES
TABLE 125. BIOHIT OYJ: COMPANY SNAPSHOT
TABLE 126. BIOHIT OYJ: PRODUCT SEGMENTS
TABLE 127. BIOHIT OYJ: PRODUCT PORTFOLIO
TABLE 128. BIOHIT OYJ: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN HELICOBACTER PYLORI DIAGNOSTICS MARKET (2023-2032)
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALHELICOBACTER PYLORI DIAGNOSTICS MARKET
FIGURE 10. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR NON-INVASIVE TEST, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR INVASIVE TEST, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR LABORATORY BASED TEST, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR POINT OF CARE TEST, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR DIAGNOSTICS LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. HELICOBACTER PYLORI DIAGNOSTICS MARKET BY REGION, 2022
FIGURE 21. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 22. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 23. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 24. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 25. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 26. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 27. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 28. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 29. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 30. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 31. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 32. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 33. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 34. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 36. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 37. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 38. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: HELICOBACTER PYLORI DIAGNOSTICS MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2022
FIGURE 47. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
FIGURE 48. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 49. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
FIGURE 50. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
FIGURE 51. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. F. HOFFMANN-LA ROCHE LTD.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 57. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 58. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 59. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 60. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. AVANOS MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 63. AVANOS MEDICAL, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. QUIDEL CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 65. QUIDEL CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 66. QUIDEL CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 67. BIOHIT OYJ: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 68. BIOHIT OYJ: REVENUE SHARE BY REGION, 2022 (%)

$5,730
$3,840
$6,450
$9,600

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings